Literature DB >> 1455155

Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion.

A Gottsäter1, M Landin-Olsson, P Fernlund, B Gullberg, A Lernmark, G Sundkvist.   

Abstract

Insulin and C-peptide responses to 0.5 g kg-1 intravenous glucose and 1.0 mg glucagon were studied in 34 healthy subjects (age 19-78 years, mean 45). Fasting blood glucose (r = 0.59; p < 0.001) and glycosylated haemoglobin (r = 0.61; p < 0.001) increased with age, but not the initial C-peptide and insulin responses to the glucose infusion. However, the C-peptide response at 70 min (r = 0.36; p < 0.05), 80 min (r = 0.41; p < 0.05), and 90 min (r = 0.46; p < 0.01) after the glucose infusion correlated with age as well as both insulin (r = 0.42; p < 0.05) and C-peptide (r = 0.45; p < 0.05) responses to the glucagon injection. Reproducibility of insulin and C-peptide responses was evaluated by duplicate tests, separated 2-143 days in time, in 10 healthy subjects (age 19-48 years, mean 32 years) showing no significant differences in median within-subject variation between the initial (1 + 3 min) or overall (0-90 min area under curve) insulin (24% and 17%, respectively) and C-peptide (15% and 14%, respectively) responses to glucose, while the within-subject variation for the fasting values and the response to glucagon was higher (p < 0.05) for insulin (47% and 32%, respectively) than C-peptide (13% and 14%, respectively). Between-subject variation was also lower (p < 0.001) for C-peptide than for insulin. Thus, C-peptide measurements in healthy subjects are more reproducible than insulin measurements in determination of beta-cell function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1455155     DOI: 10.3109/00365519209115506

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).

Authors:  H Borg; H J Arnqvist; E Björk; J Bolinder; J W Eriksson; L Nyström; J-O Jeppsson; G Sundkvist
Journal:  Diabetologia       Date:  2003-02-08       Impact factor: 10.122

2.  HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.

Authors:  E Bakhtadze; H Borg; G Stenström; P Fernlund; H J Arnqvist; A Ekbom-Schnell; J Bolinder; J W Eriksson; S Gudbjörnsdottir; L Nyström; L C Groop; G Sundkvist
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

3.  Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Authors:  E Vandemeulebroucke; B Keymeulen; K Decochez; I Weets; C De Block; F Féry; U Van de Velde; I Vermeulen; P De Pauw; C Mathieu; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

4.  Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients.

Authors:  A Gottsäter; M Landin-Olsson; A Lernmark; P Fernlund; G Sundkvist
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

5.  [Effect of resection or duct drainage on glucose stimulated beta cell function in chronic pancreatitis].

Authors:  J W Heise; H Becker; C Niederau; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1994

6.  Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients.

Authors:  Hye-Jin Yoon; Youn-Zoo Cho; Ji-Young Kim; Byung-Joon Kim; Keun-Young Park; Gwan-Pyo Koh; Dae-Ho Lee; Dong-Mee Lim
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

7.  C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index.

Authors:  Jong Dai Kim; Sung Ju Kang; Min Kyung Lee; Se Eun Park; Eun Jung Rhee; Cheol Young Park; Ki Won Oh; Sung Woo Park; Won Young Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.